【UnicoCell Biomed】March 2026 Revenue NT$0.02 Billion (YoY -66.4%)

Key facts

  • 【UnicoCell Biomed】March 2026 Revenue NT$0.02 Billion (YoY -66.4%)
  • Biotechnology company UnicoCell Biomed (6794) announced that its monthly revenue for March 2026 was NT$0.02 billion, a significant decrease of 66.4% year-over-year.
  • Source: PR Times
  • Date: March 1, 2026

Direct answer

Biotechnology company UnicoCell Biomed (6794) announced that its monthly revenue for March 2026 was NT$0.02 billion, a significant decrease of 66.4% year-over-year.

Citation
【UnicoCell Biomed】March 2026 Revenue NT$0.02 Billion (YoY -66.4%) (March 1, 2026), PR Times
Source
PR Times
Date
March 1, 2026
Biotechnology company UnicoCell Biomed (6794) announced that its monthly revenue for March 2026 was NT$0.02 billion, a significant decrease of 66.4% year-over-year.
その他NQ 19/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: March 1, 2026 at 09:00
  • 🔍 Collected: April 12, 2026 at 16:30 (1015h 30m after Published)
  • 🤖 AI Analyzed: April 13, 2026 at 11:13 (18h 43m after Collected)
Company Code: 6794
Company Name: UnicoCell Biomed
Industry: Biotechnology and Medical Care
Data Month: 2026-03
Monthly Revenue: 1,869 thousand NTD (0.02 billion)
Year-on-Year Change: -66.4%

FAQ

What are the key facts in this article?

Biotechnology company UnicoCell Biomed (6794) announced that its monthly revenue for March 2026 was NT$0.02 billion, a significant decrease of 66.4% year-over-year.

What is the direct answer?

Biotechnology company UnicoCell Biomed (6794) announced that its monthly revenue for March 2026 was NT$0.02 billion, a significant decrease of 66.4% year-over-year.

What is the source and date?

PR Times: https://openapi.twse.com.tw/revenue/twse-rev-6794-11503 | March 1, 2026